Is your child displaying symptoms of ADHD?

Is your child displaying symptoms of ADHD?

A Multicenter, Dose-Optimized, Randomized, Double-Blind, Efficacy and Safety Study with Azstarys® in Children 4 to 12 Years of Age with Attention-Deficit/Hyperactivity Disorder.

Unhappy mommy with daughter

The Study

  • The study is to treat children with ADHD
  • ADHD occurs in 6% to 8% of children worldwide
  • The goal of the study medication is to alleviate ADHD symptoms with the primary symptoms being inattention, hyperactivity, and impulsivity.

Study Benefits:

  • Study medication is a capsule taken daily and is already approved in children 6 to 12 years old as well as adolescents.
  • Has been shown to improve ADHD symptoms in multiple studies.
  • There is an option to enroll in a 12-month open label extension (if qualified).
  • Close medical care while participating in the trial.

Study Participant Criteria :

  • 4 to 5 years of age
  • Cannot have been on amphetamines at any time.
  • Cannot be on any other ADHD medication during the study.
  • Subject must meet criteria for primary diagnosis of ADHD according to the DSM-V

Study Participant Expectations:

  • Treatment period of 5 weeks with weekly clinic visits
  • Daily oral medication
  • Compensation for time and travel

“Did You Know”

  • ADHD symptoms affect school performance, extracurricular activities, and home activities.
  • ADHD is theorized to result from a deficiency of neurotransmission of dopamine and norepinephrine either through the insufficient sensitivity of the receptors or amount of dopamine produced

Register for a Study